6550--NTX Ventana Reagents

SOL #: 36C25726Q0105Award NoticeSole Source

Overview

Buyer

Veterans Affairs
Veterans Affairs, Department Of
257-NETWORK CONTRACT OFFICE 17 (36C257)
San Antonio, TX, 78240, United States

Place of Performance

Place of performance not available

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

PSC

In Vitro Diagnostic Substances, Reagents, Test Kits And Sets (6550)

Set Aside

No set aside specified

Timeline

1
Posted
Feb 3, 2026
2
Last Updated
Apr 22, 2026

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Department of Veterans Affairs (VA), Network Contracting Office 17, has awarded a Firm-Fixed-Price Indefinite Delivery/Indefinite Quantity (IDIQ) contract to Roche Diagnostics Corporation for Ventana reagents and consumable supplies. This award, valued at $1,400,000.00, supports the North Texas Health Care System's Pathology & Laboratory Medicine Service.

Scope of Work

The contract covers the procurement of essential reagents and consumable supplies, including but not limited to DAB Detection reagent, Hematoxylin, various staining kits (e.g., Elastin Van Gieson Kit), antibodies (e.g., Confirm Anti-Thyroid Transcription Factor, Confirm Cytokeratin7 Rabbitmono, Antibody – KI 67), printer ribbons, and IHC ancillaries. These items are exclusively compatible with the government-owned Ventana BenchMark Ultra and Ventana HE600 systems. Supplies will be ordered on an as-needed basis.

Contract & Timeline

  • Awardee: Roche Diagnostics Corporation (UEI JDMDFEZBYH36)
  • Contract Type: Firm-Fixed-Price (FFP) Indefinite Delivery/Indefinite Quantity (IDIQ)
  • Award Number: 36C25726D0065
  • Award Amount: $1,400,000.00 (ceiling)
  • Award Date: April 21, 2026
  • Period of Performance: Five one-year ordering periods, from April 19, 2026, through April 18, 2031.
  • Set-Aside: None (Sole Source)
  • Product Service Code (PSC): 6550 (In Vitro Diagnostic Substances, Reagents, Test Kits And Sets)
  • NAICS Code: 325413 (In-Vitro Diagnostic Substance Manufacturing)

Justification & Evaluation

This acquisition was conducted as a sole source award under statutory authorities permitting other than full and open competition (41 U.S.C. 3304(a)(1) and FAR 6.302-1). The justification is based on the unique qualifications of Ventana Medical Systems, Inc. (a member of the Roche Group) as the exclusive manufacturer of the required reagents and supplies, which are indispensable for the operation of the VA's existing Ventana BenchMark Ultra and HE600 systems. Market research, including a Special Notice on SAM.gov from February 3-9, 2026, did not identify any other responsible sources capable of meeting these specific requirements.

Contact Information

For inquiries regarding this award, contact Susan Flores, Contract Specialist, at Susan.flores2@va.gov or (210) 694-6227.

People

Points of Contact

Susan FloresContract SpecialistPRIMARY

Files

Files

Download
Download
Download

Versions

Version 3Viewing
Award Notice
Posted: Apr 22, 2026
Version 2
Special Notice
Posted: Apr 22, 2026
View
Version 1
Special Notice
Posted: Feb 3, 2026
View
6550--NTX Ventana Reagents | GovScope